Cargando…
The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United States
This economic evaluation aims to support policy-making on the combined use of pre-exposure prophylaxis (PrEP) with HIV vaccines in development by evaluating the potential cost-effectiveness of implementation that would support the design of clinical trials for the assessment of combined product safe...
Autores principales: | Adamson, Blythe J. S., Carlson, Josh J., Kublin, James G., Garrison, Louis P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492010/ https://www.ncbi.nlm.nih.gov/pubmed/28538691 http://dx.doi.org/10.3390/vaccines5020013 |
Ejemplares similares
-
Competing biomedical HIV prevention strategies: potential cost‐effectiveness of HIV vaccines and PrEP in Seattle, WA
por: Adamson, Blythe, et al.
Publicado: (2019) -
Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling study
por: de Montigny, Simon, et al.
Publicado: (2018) -
Pre-exposure prophylaxis of HIV
por: Naswa, Smriti, et al.
Publicado: (2011) -
Pre-exposure prophylaxis in HIV
por: Khambhati, Ravi, et al.
Publicado: (2009) -
HIV: Pre-exposure Prophylaxis
por: Singh, Ajai Kumar, et al.
Publicado: (2012)